Wanda Phipatanakul, MD, MS
Professor of Pediatrics
Harvard Medical School
Director, Asthma Clinical Research Center
Boston Children's Hospital
Boston, MA

Wanda Phipatanakul, MD, MS is Director of the Asthma Clinical Research Center at Boston Children’s Hospital and Professor of Pediatrics at Harvard Medical School. She has dedicated her career to reducing and preventing asthma and allergic diseases.

Originally from St. Louis, she earned her medical degree from Loma Linda University and completed her residency in pediatrics at Children’s Hospital Los Angeles in 1997. After a fellowship in immunology at Johns Hopkins University, she joined the faculty in the Division of Immunology and Allergy at Boston Children’s and Harvard Medical School, where she has remained for the past 19 years.

Dr. Phipatanakul has built a deep network of community relationships and conducts both school- and home-based asthma studies in children. She has also had continuous National Institutes of Health (NIH) funding for nearly 20 years. She leads the National Institute of Allergy and Infectious Diseases (NIAID) School Inner-City Asthma Intervention Study and the National Heart, Lung, and Blood Institute (NHLBI) Environment Assessment of Sleep in Youth. She is the overall Principal Investigator for an NIAID-funded, nationwide, multicenter asthma-prevention study evaluating omalizumab (anti-IgE) in preventing the atopic march and asthma.

Most recently, Dr. Phipatanakul was awarded an NIAID U01 evaluating whether patients carrying an IL4RαR576gene variant will have a greater response to dupilumab. She leads her Center as Pediatric PI in multiple NHLBI asthma and prevention networks, including Precise, and has authored more than 260 publications in scientific journals, including JAMA and the New England Journal of Medicine. She is passionate about successfully mentoring the next generation of investigators, serving the American Academy of Allergy, Asthma & Immunology (AAAAI) and the American Board of Allergy and Immunology (ABAI) in support of her specialty, and serving as a role model to others balancing work and family.

Jay M. Portnoy, MD
Professor of Pediatrics
University of Missouri-Kansas City School of Medicine
Staff Allergist and Medical Director of Telemedicine
Children’s Mercy Hospital
Kansas City, MO

Jay M. Portnoy, MD is an allergist in the section of Allergy, Asthma & Immunology and Medical Director of Telemedicine at Children’s Mercy Hospital in Kansas City, Missouri and Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine. He received his medical degree at the University of Missouri-Columbia School of Medicine, and he did his pediatric residency at the Children’s Mercy Hospital in Kansas City and his Allergy fellowship at the University of Michigan in Ann Arbor. Following that he returned to Children’s Mercy Hospital.

Dr. Portnoy has published numerous articles in peer-reviewed journals involving asthma disease management, environmental control, mold allergy. More recently he has been involved in evidence-based medicine and Telemedicine and was co-chair of the Joint Taskforce on Practice Parameters. He was co-director of the Kansas University Medical School allergy program from 1985 to 1997 and he founded the UMKC School of Medicine allergy program and directed it from 1997-2006.Dr. Portnoy served as President of the American College of Allergy, Asthma & Immunology in 2008 and he has served on numerous committees both of the American College and the American Academy of Allergy, Asthma & Immunology as well as on the Allergy/Immunology Residency Review Committee of the ACGME and the American Board of Allergy and Immunology.

He lives in Overland Park, KS with his wife and 2 cats. Fortunately, nobody in the family has cat allergy.

Jodi Shroba, MSN, APRN, CPNP
Certified Pediatric Nurse Practitioner
Food Allergy Program Coordinator, Allergy Division
Children’s Mercy Hospital
Kansas City, MO

Jodi Shroba, MSN, APRN, CPNP is a certified pediatric nurse practitioner at Children’s Mercy Hospital in Kansas City. She received her Master of Nursing degree from University of Missouri Kansas City in 2007 and joined the Division of Allergy, Asthma and Immunology upon graduation. In addition to her clinical practice, she is the Food Allergy Program Coordinator for the Allergy Division. Jodi is also actively involved in research and education. She has spoken both locally and nationally on the topics of asthma, allergic rhinitis and food allergies.

Ashley M. Thomas, PharmD, BCPS, BCACP, CACP
Clinical Pharmacy Specialist, Primary Care
Nashville, TN

Ashley M. Thomas, PharmD, BCPS, BCACP, CACP graduated with a Doctor of Pharmacy degree from Samford University McWhorter School of Pharmacy. She completed a post-graduate year 1 residency at Tennessee Valley Healthcare System. She went on to complete a post-graduate year 2 residency at Tennessee Valley Healthcare System specializing in ambulatory care. Ashley is a board-certified pharmacotherapy and ambulatory care pharmacy specialist. She currently works in a primary care clinic assisting in the management of chronic disease states under a scope of practice. Ashley enjoys regularly training students and residents, both medical and pharmacy. She also is a guest-lecturer in ambulatory care topics for Belmont and Lipscomb colleges of pharmacy. Ashley works on a national primary care pharmacy subject matter expert group and has delivered several national teleconference presentations. She is actively involved in local clinical research projects serving as a local research advisory board member for pharmacy resident projects. Ashley has been delivery care to patients through telemedicine for the past 2 years in addition to face to face and telephonic care.

DISCLOSURE INFORMATION

The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

Program Faculty
The faculty, authors and content developers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Wanda Phipatanakul, MD, MS: Consultant/Independent Contractor: Genentech/Novartis, GlaxoSmithKline, Regeneron/Sanofi;Grant/Research Support: Alk Abello, Circassia, Genentech/Novartis, Kaleo, Regeneron/Sanofi

Jay M. Portnoy, MD: Nothing to disclose

Jodi Shroba, MSN, APRN, CPNP: Honoraria: Aimmune; Speaker's Bureau: Aimmune

Ashley M. Thomas, PharmD, BCPS, BCACP, CACP: Nothing to disclose

Planners and Managers
The planners and mangers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Chad Williamson, MS, MBA, CMPP: Nothing to disclose

Content Reviewers
The content reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Katie Propst, PhD: Nothing to disclose

FDA DISCLOSURE

The contents of some CME/CPE/CNE/MOC activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.